Managed Health Care Connect February 9, 2018
Eileen Koutnik-Fotopoulos

One year ago, the FDA released the health care economic information (HCEI) draft guidance on approved communication between pharmaceutical manufacturers and health care decision-makers, including payers, formulary committees, or similar entities. First Report Managed Care spoke with stakeholders for their insights and experiences on why access to HCEI is critical to better care for patients, how the guidance has impacted payers, why it is important to continue incorporating HCEI into decision making while waiting for FDA to finalize the guidelines, and where industry stands on HCEI a year later.

The Value of Access

HCEI, which is part of the 21st Century Cures Act, is an important consideration during the formulary decision-making process, according to Jay Jackson, PharmD, MPH, senior vice...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Cures Act, FDA, Payer
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article